✦ LIBER ✦

IIIB.3 Targeted therapies and chemotherapy: new challenge for the treatment of advanced NSCLC elderly patients

✍ Scribed by Gridelli, C.

Book ID: 121784717
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 44 KB
Volume: 60
Category: Article
ISSN: 1040-8428
DOI: 10.1016/S1040-8428(13)70023-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Medical treatment of advanced non-small

Medical treatment of advanced non-small cell lung cancer in elderly patients: A review of the role of chemotherapy and targeted agents

✍ Meoni, Giulia; Cecere, Fabiana Letizia; Lucherini, Elisa; Di Costanzo, Francesco 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 239 KB

Economic evaluation of new targeted ther

Economic evaluation of new targeted therapies for the first-line treatment of patients with metastatic renal cell carcinoma

✍ Ágnes Benedict; Robert A. Figlin; Per Sandström; Ulrika Harmenberg; Anders Ullén 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

Concomitant radiation therapy and target

Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: Disease control and preservation of organ function

✍ Sandeep Samant; Parvesh Kumar; Jim Wan; Cathy Hanchett; Francisco Vieira; Tom Mu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

Background. Squamous cell carcinoma of the pyriform sinus is an unfavorable disease which frequently presents in advanced stages. Despite aggressive "standard treatment" involving debilitating surgery and postoperative radiation therapy treatments, the survival and functional outcome for pyriform si

P-488 Phase II randomized trial of singl

P-488 Phase II randomized trial of single-agent pemetrexed orsequentially administered pemetrexed/gemcitabine as front-line chemotherapy for the treatment of advanced non-small cell lung cancer (NSCLC) in elderly patients or patients ineligible for platinum-based chemotherapy

✍ Gridelli, C.; Reck, M.; Gregorc, V.; Migliorino, M.; Muller, T.; Manegold, C.; F 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB

PCN43 THE ASSOCIATION OF TUMOR HISTOLOGY

PCN43 THE ASSOCIATION OF TUMOR HISTOLOGY WITH FIRST-LINE TREATMENT AND LIFETIME MEDICAL-CARE COSTS AMONG ELDERLY STAGE IIIB/IV NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH COMMONLY USED DOUBLET THERAPIES AMONG

✍ K Lang; M Marciniak; D Faries; KM Clements; J Nyambose; C Earle; K Sugarman; D T 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PCN44 TREATMENT COSTS OF GRADE 3/4 ADVER

PCN44 TREATMENT COSTS OF GRADE 3/4 ADVERSE EVENTS RELATED TO FIRST-LINE THERAPY WITH BEVACIZUMAB PLUS CHEMOTHERAPY VERSUS CETUXIMAB PLUS CISPLATIN/VINORELBINE FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN SPAIN

✍ J de Castro Carpeño; K Banz; AJ Castro 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB